Khiron Life Sciences Corp. to Present at Virtual Investor Conference
Live Webcast Scheduled for September 12, 2018, 2:00pm EDT, followed by Q&A
TORONTO, Sept. 12, 2018 /CNW/ -- KHIRON LIFE SCIENCES CORP. ("Khiron" or the "Company") (TSXV: KHRN, OTCQB: KHRNF), a Canadian integrated medical cannabis company with core operations in Colombia, announced that Darren Collins, Chief Financial Officer, will present live at VirtualInvestorConferences.com on September 12, 2018. Individual and institutional investors, as well as advisors are invited to join the live webcast followed by a Q&A with Mr. Collins.
DATE: Wednesday, September 12, 2018
TIME: 2:00 PM EDT
LINK: https://tinyurl.com/0912prepr
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- Listed on OTCQB Venture Market with the Symbol OTCQB: KHRNF
- Signed Letter of Intent to Acquire Colombia's Leading Health Network
- Appointed Former Mexican President Vicente Fox to Board of Directors
- Expanded Medical Cannabis Cultivation Capacity
About Khiron Life Sciences Corp.
Khiron Life Sciences Corp. (TSXV: KHRN, OTCQB: KHRNF) ("Khiron" or the "Company") is positioned to be the dominant integrated medical cannabis company in Latin America. Khiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. In May 2018, Khiron listed on the TSXV, becoming the first Colombian based medical cannabis company to trade on any exchange globally.
With a focused regional strategy and patient oriented approach, the Company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people. Khiron is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced executive team, and a knowledgeable Board of Directors that includes former President of Mexico, Vicente Fox.
Further information on Khiron life Sciences can be found at www.khiron.ca.
About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
Forward-looking statements
This news release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Forward-looking statements herein include but are not limited to statements regarding the Offering, anticipated timing of the filing of the final short form prospectus, the closing of the Offering, the use of proceeds, the receipt of requisite TSXV and securities regulatory approvals, and are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market and economic risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Except as required by law, the Company disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned not to put undue reliance on these forward-looking statements.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
Further information in respect of the Company can be found at www.khiron.ca.
SOURCE Khiron Life Sciences Corp.
Khiron Life Sciences Corp.: Chris Naprawa, President, +1 (416) 705-1144, [email protected]; Darren Collins, Chief Financial Officer, +1 (705) 527-3564, [email protected]; Media Contact: Jon Packer, Vice President, Communications, +1 (416) 543-9179, [email protected]; VirtualInvestorConferences.com: John M. Viglotti, [email protected], http://www.khiron.ca
Share this article